SCHEMBL5884299

SCHEMBL5884299

CCc1nc(C2=CC=C2)n2nc(-c3cccc(Cl)c3)[nH]c(=O)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.37
CCNE2 O96020 5/20 0.36
CCNE1 P24864 5/20 0.36
CDK2 P24941 5/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
CCNB2 O95067 3/20 0.35
CDK1 P06493 3/20 0.35
CDK4 P11802 3/20 0.35
CCNB1 P14635 3/20 0.35
CCND1 P24385 3/20 0.35
CCNB3 Q8WWL7 3/20 0.35
DHFR P00374 1/20 0.35
PDE2A O00408 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
TYMP P19971 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5883954 0.88 MEN1 (0.38) PIN1MGAMGAASIMGAM2
SCHEMBL5884374 0.88 NPC1 (0.37) ALDH1A1POLBAPOBEC3GTYMPPDE5A
SCHEMBL5884367 0.87 PDE5A (0.45) ALDH1A1POLBPDE5A
SCHEMBL5884437 0.83 TNKS (0.37) PDE2APDE5A
SCHEMBL5883909 0.81 TNKS (0.37) PDE2APDE5A
SCHEMBL5729050 0.80 ALDH1A1 (0.38) ALDH1A1ADORA3PDE5A
SCHEMBL5859643 0.79 ADORA2B (0.39) GAAPDE2AALDH1A1ADORA3PDE5A
SCHEMBL5883866 0.79 PDE5A (0.41) ALDH1A1PDE5A
SCHEMBL5884296 0.77 PDE5A (0.48) PIN1CCNE2CCNE1CDK2DHFR
SCHEMBL5884403 0.77 PDE5A (0.50) PIN1CCNE2CCNE1CDK2DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087605-B2 5-Ethyl-imidazotriazinones BAYER AKTIENGESELLSCHAFT (DE) 2006-08-08 US disclosed
EP-1397363-B1 5-ETHYL-IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2005-05-11 EP disclosed
US-20040254187-A1 5-ethyl-imidazotriazinones BAYER HEALTHCARE AG (DE) 2004-12-16 US disclosed
EP-1397363-A1 5-ETHYL-IMIDAZOTRIAZINONES Bayer HealthCare AG (DE) 2004-03-17 EP disclosed
WO-2002098880-A1 5-ETHYL-IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254187-A1 5-ethyl-imidazotriazinones EPX, TPMT, IL5 PIN1 1065/4885CCNE2 3007/4885CCNE1 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.